Glucagon-Like Peptide 1 Receptor Agonists Are Not Associated With an Increased Risk of Ileus or Intestinal Obstruction in Patients with Inflammatory Bowel Disease—A Danish Nationwide Cohort Study
This study suggests that GLP-1RAs do not increase the risk of ileus or intestinal obstruction in patients with IBD.
Authors
- Torben Knudsen (ORCID: https://orcid.org/0000-0003-0726-0115)
- Bente Mertz Nørgård (ORCID: https://orcid.org/0000-0002-9514-3033)
- Jan Nielsen (ORCID: https://orcid.org/0000-0002-7634-6812)
- Sonia Friedman (ORCID: https://orcid.org/0000-0002-2720-4404)
- Jens Kjeldsen (ORCID: https://orcid.org/0000-0001-8148-6572)
- Mette Wod (ORCID: https://orcid.org/0000-0001-9765-7321)
Institutions
- Tufts University (US)
- Tufts Medical Center (US)
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Hospital South West Jutland (DK)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/ibd/izae276
- Citations
- 12
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.29